(Q55051234)

16 June 2018

title

Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. (English)

1 reference

16 June 2018

chronic lymphocytic leukemia

0 references

1 reference

1 reference

1 reference

M Baou

1

1 reference

16 June 2018

A Jewell

2

1 reference

16 June 2018

A Muthurania

3

1 reference

16 June 2018

R G Wickremasinghe

4

1 reference

16 June 2018

K L Yong

5

1 reference

16 June 2018

R Carr

6

1 reference

16 June 2018

P Marsh

7

1 reference

16 June 2018

J J Murphy

8

1 reference

16 June 2018

publication date

18 December 2008

1 reference

16 June 2018

published in

Leukemia

1 reference

16 June 2018

volume

23

1 reference

16 June 2018

issue

5

1 reference

16 June 2018

page(s)

986-989

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1038/leu.2008.340

exact match

0 references

cites work

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.340

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.340

1 reference

16 June 2018

Dimensions Publication ID

1006223508

0 references

1 reference

16 June 2018